BMC Cancer 2008, 8:379 http://www.biomedcentral.com/1471-2407/8/379 Authors' contributions ZP carried out the design, analysis of pathology and drafted the manuscript. LY carried out sample collecting and co-ordination. LL performed the immunohistochem- ical staining. ZM carried out slide sectioning. All authors read and approved the manuscript. Acknowledgements We thank Dr Mao and Mrs Vannoorden in Department of Pathology, Ham- mersmith Hospital, Imperial College, London, UK for their important Eng- lish revising and editing the manuscript. References 1. Stein H, Delsol G, Pileri S, Said J, Mann R, Poppema S, Jaffe ES, Swer- dlow SH: Classical Hodgkin lymphoma. In World Health Organi- zation classification of tumours – tumours of haematopoeitic and lymphoid tissues Volume Chapter 8. Edited by: Jaffe ES, Harris NL, Stein H, Var- diman JW. IARC press, Lyon, France; 2001:244-253. 2. Perk J, Iavarone A, Benezra R: Id family of helix-loop-helix pro- teins in cancer. Nat Rev Cancer 2005, 5:603-614. 3. Medina KL, Pongubala JM, Reddy KL, Lancki DW, Dekoter R, Kieslin- ger M, Grosschedl R, Singh H: Assembling a gene regulatory net- work for specification of the B cell fate. Dev Cell 2004, 7:607-617. 4. Engel I, Murre C: The function of E- and Id proteins in lym- phocyte development. Nat Rev Immunol 2001, 1:193-199. 5. Roberts EC, Deed RW, Inoue T, Norton JD, Sharrocks AD: Id helix- loop-helix proteins antagonize pax transcription factor activ- ity by inhibiting DNA binding. Mol Cell Biol 2001, 21:524-533. 6. Ishiguro A, Spirin KS, Shiohara M, Tobler A, Gombart AF, Israel MA, Norton JD, Koeffler HP: Id2 expression increases with differen- tiation of human myeloid cells. Blood 1996, 87:5225-5231. 7. Cooper CL, Brady G, Bilia F, Iscove NN, Quesenberry PJ: Expres- sion of the Id family helix-loop-helix regulators during growth and development in the hematopoietic system. Blood 1997, 89:3155-3165. 8. Spits H, Couwenberg F, Bakker AQ, Weijer K, Uittenbogaart CH: Id2 and Id3 inhibit development of CD34(+) stem cells into pre- dendritic cell (pre-DC)2 but not into pre-DC1evidence for a lymphoid origin of pre-DC2. J Exp Med 2000, 192:1775-1784. 9. Hacker C, Kirsch RD, Ju XS, Hieronymus T, Gust TC, Kuhl C, Jorgas T, Kurz SM, Rose-John S, Yokota Y, Zenke M: Transcriptional pro- filing identifies Id2 function in dendritic cell development. Nat Immunol 2003, 4:380-386. 10. Buitenhuis M, van Deutekom HW, Verhagen LP, Castor A, Jacobsen SE, Lammers JW, Koenderman L, Coffer PJ: Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2. Blood 2005, 105:4272-4281. 11. Underhill GH, George D, Bremer EG, Kansas GS: Gene expression profiling reveals a highly specialized genetic program of plasma cells. Blood 2003, 101:4013-4021. 12. Hertel CB, Zhou XG, Hamilton-Dutoit SJ, Junker S: Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma. Oncogene 2002, 21:4908-4920. 13. Gonda H, Sugai M, Nambu Y, Katakai T, Agata Y, Mori KJ, Yokota Y, Shimizu A: The balance between Pax5 and Id2 activities is the key to AID gene expression. J Exp Med 2003, 198:1427-1437. 14. Renné C, Martin-Subero JI, Eickernjäger M, Hansmann ML, Küppers R, Siebert R, Bräuninger A: Aberrant Expression of ID2, a Sup- pressor of B-Cell-Specific Gene Expression, in Hodgkin's Lymphoma. Am J Pathol 2006, 169:655-664. 15. Li HM, Zhuang ZH, Wang Q, Pang JC, Wang XH, Wong HL, Feng HC, Jin DY, Ling MT, Wong YC, Eliopoulos AG, Young LS, Huang DP, Tsao SW: Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epi- thelial cells. Oncogene 2004, 23:4488-4494. 16. Everly DNJr, Mainou BA, Raab TN: Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regula- tion of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation. J Virol 2004, 78:13470-13478. 17. O'Neill CJ, McCluggage WG: p16 expression in the female geni- tal tract and its value in diagnosis. Adv Anat Pathol 2006, 13:8-15. 18. Kim LH, Peh SC, Poppema S: Expression of retinoblastoma pro- tein and P16(INK4A) proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein- Barr virus in the regulation of cell growth and death. Hum Pathol 2006, 37:92-100. 19. Cotta CV, Medeiros LJ: Expression of Helix-Loop-Helix Pro- teins in Classical Hodgkin Lymphoma: A Possible Explana- tion for a Characteristic Immunophenotype. Adv Anat Pathol 2008, 15:97-104. 20. Mathas S, Janz M, Hummel F, Hummel M, Wollert-Wulf B, Lusatis S, Anagnostopoulos I, Lietz A, Sigvardsson M, Jundt F, Jöhrens K, Bom- mert K, Stein H, Dörken B: Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates repro- gramming of neoplastic B cells in Hodgkin lymphoma. Nature Immunology 2006, 7:207-215. 21. Landgren O, Caporaso NE: New aspects in descriptive, etio- logic, and molecular epidemiology of Hodgkin's lymphoma. Hematol Oncol Clin North Am 2007, 21:825-840. 22. Brocksmith D, Angel CA, Pringle JH, Lauder I: Epstein-Barr viral DNA in Hodgkin's disease: amplification and detection using the polymerase chain reaction. J Pathol 1991, 165:11-15. 23. Chang KC, Khen NT, Jones D, Su IJ: Epstein-Barr virus is associ- ated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype. Hum Pathol 2005, 36:747-755. 24. Zhou X, Li P, Ji X: [Detection of Epstein-Barr virus subtypes in Hodgkin's disease.]. Zhonghua Bing Li Xue Za Zhi 1998, 27:255-257. 25. Chang KC, Chen PC, Jones D, Su IJ: Changing patterns in the fre- quency of Hodgkin lymphoma subtypes and Epstein-Barr virus association in Taiwan. Cancer Sci 2008, 99:345-349. 26. Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A: Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 2000, 407:592-598. 27. Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y, Sharrocks AD, Peters G, Hara E: Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 2001, 409:1067-1070. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/8/379/pre pub Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime." Sir Paul Nurse, Cancer Research UK Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp BioMedcentral Page 5 of 5 (page number not for citation purposes)